Literature DB >> 7957551

Membrane CD45R isoform exchange on CD4 T cells is rapid, frequent and dynamic in vivo.

S M Sparshott1, E B Bell.   

Abstract

CD4 T cells bearing high (240-190 kDa) and low (180 kDa) molecular mass isoforms of the leukocyte common antigen CD45 define functionally distinct subsets which have been equated with naive and memory T cells. In the rat, CD4 T cells expressing a high molecular mass isoform [identified by monoclonal antibody MRC-OX22 (anti-CD45RC)] exchange this for the 180 kDa molecule (CD45RC-) when stimulated by antigen. Here we show, by transferring mature allotype-marked CD45RC- CD4 T cells (depleted of immature Thy-1+ CD45RC- recent thymic emigrants) into normal euthymic recipients, that many T cells re-express the high molecular mass isoform in less than 6 h. By 24 h, 30-60% of CD45RC- CD4 T cells became CD45RC+; within a week the entire cohort appeared to exchange the low for the high molecular mass isoform. Isoform exchange was dynamic and many CD4 T cells returned once again to the CD45RC- state. CD45RC- CD4 T cells declined in number more rapidly than the CD45RC+ subset after transfer. The results suggest that CD45R isoforms distinguish between resting T cells (CD45RC+) and those which have encountered antigen in the recent past. CD45R isoforms would appear to be unsuitable markers of naive and memory T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957551     DOI: 10.1002/eji.1830241102

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

Review 1.  Differences in the regulation of CD4 and CD8 T-cell clones during immune responses.

Authors:  P C Beverley; M K Maini
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

Review 2.  Local immune responses in afferent and efferent lymph.

Authors:  D M Haig; J Hopkins; H R Miller
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

Review 3.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

4.  CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice.

Authors:  P Andersen; B Smedegaard
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Naive T-cell receptor transgenic T cells help memory B cells produce antibody.

Authors:  Darragh Duffy; Chun-Ping Yang; Andrew Heath; Paul Garside; Eric B Bell
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

6.  Regulation of T-cell activation in the lung: isolated lung T cells exhibit surface phenotypic characteristics of recent activation including down-modulated T-cell receptors, but are locked into the G0/G1 phase of the cell cycle.

Authors:  D Strickland; U R Kees; P G Holt
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

7.  Identical expression of CD45R isoforms by CD45RC+ 'revertant' memory and CD45RC+ naive CD4 T cells.

Authors:  M Hargreaves; E B Bell
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

8.  Naive human alpha beta T cells respond to membrane-associated components of malaria-infected erythrocytes by proliferation and production of interferon-gamma.

Authors:  S Dick; M Waterfall; J Currie; A Maddy; E Riley
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

9.  Influence of PMN leukocyte-mediated pancreatic damage on the systemic immune response in severe acute pancreatitis in rats.

Authors:  Uwe A Wittel; Bettina Rau; Frank Gansauge; Susanne Gansauge; Andreas K Nussler; Hans G Beger; Bertram Poch
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

10.  Immunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection.

Authors:  Darragh Duffy; Amina Dawoodji; Else Marie Agger; Peter Andersen; Jürgen Westermann; Eric B Bell
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.